104 related articles for article (PubMed ID: 30611981)
1. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin.
Serrano-Aparicio N; Świderek K; Moliner V
Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and Electrostatic Effects on the Reaction Catalyzed by HIV-1 Protease.
Krzemińska A; Moliner V; Świderek K
J Am Chem Soc; 2016 Dec; 138(50):16283-16298. PubMed ID: 27935692
[TBL] [Abstract][Full Text] [Related]
3. Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Meng L; Kwok BH; Sin N; Crews CM
Cancer Res; 1999 Jun; 59(12):2798-801. PubMed ID: 10383134
[TBL] [Abstract][Full Text] [Related]
4. Covalent Inhibition of the
Serrano-Aparicio N; Ferrer S; Świderek K
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631358
[TBL] [Abstract][Full Text] [Related]
5. Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin.
Wei D; Lei B; Tang M; Zhan CG
J Am Chem Soc; 2012 Jun; 134(25):10436-50. PubMed ID: 22697787
[TBL] [Abstract][Full Text] [Related]
6. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome.
Keller L; Plaza A; Dubiella C; Groll M; Kaiser M; Müller R
J Am Chem Soc; 2015 Jul; 137(25):8121-30. PubMed ID: 26050527
[TBL] [Abstract][Full Text] [Related]
7. Catalytic mechanism and product specificity of rubisco large subunit methyltransferase: QM/MM and MD investigations.
Zhang X; Bruice TC
Biochemistry; 2007 May; 46(18):5505-14. PubMed ID: 17429949
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
[TBL] [Abstract][Full Text] [Related]
9. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
[TBL] [Abstract][Full Text] [Related]
10. Role of solvent on nonenzymatic peptide bond formation mechanisms and kinetic isotope effects.
Świderek K; Tuñón I; Martí S; Moliner V; Bertrán J
J Am Chem Soc; 2013 Jun; 135(23):8708-19. PubMed ID: 23679067
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors.
Huber EM; de Bruin G; Heinemeyer W; Paniagua Soriano G; Overkleeft HS; Groll M
J Am Chem Soc; 2015 Jun; 137(24):7835-42. PubMed ID: 26020686
[TBL] [Abstract][Full Text] [Related]
12. Quantum mechanics/molecular mechanics studies of the mechanism of cysteine protease inhibition by peptidyl-2,3-epoxyketones.
Arafet K; Ferrer S; González FV; Moliner V
Phys Chem Chem Phys; 2017 May; 19(20):12740-12748. PubMed ID: 28480929
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.
Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM
Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
Groll M; Huber R
Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
[TBL] [Abstract][Full Text] [Related]
15. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
Stein RL; Melandri F; Dick L
Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
[TBL] [Abstract][Full Text] [Related]
16. Chaperone-driven proteasome assembly.
Rosenzweig R; Glickman MH
Biochem Soc Trans; 2008 Oct; 36(Pt 5):807-12. PubMed ID: 18793141
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin.
Hermann JC; Hensen C; Ridder L; Mulholland AJ; Höltje HD
J Am Chem Soc; 2005 Mar; 127(12):4454-65. PubMed ID: 15783228
[TBL] [Abstract][Full Text] [Related]
18. Catalytic mechanism of glycosyltransferases: hybrid quantum mechanical/molecular mechanical study of the inverting N-acetylglucosaminyltransferase I.
Kozmon S; Tvaroska I
J Am Chem Soc; 2006 Dec; 128(51):16921-7. PubMed ID: 17177443
[TBL] [Abstract][Full Text] [Related]
19. Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).
Wei D; Tang M; Zhan CG
Org Biomol Chem; 2015 Jun; 13(24):6857-65. PubMed ID: 26018983
[TBL] [Abstract][Full Text] [Related]
20. (-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study.
Groll M; Nguyen H; Vellalath S; Romo D
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
